Health‐Related Quality of Life and Associated Factors Among Patients With Bioprosthetic Heart Valve Replacement: A Cross‐Sectional Study

AIM: The use of bioprosthetic heart valves has significantly increased in recent years due to the aging population and advances in technology. Health-related quality of life (HRQoL) is as important as clinical outcomes. However, little is known about the long-term HRQoL of patients after bioprosthetic heart valve replacement and its relationship with comprehensive treatment adherence and family support. The aim of this study was to assess the HRQoL of patients after bioprosthetic heart valve replacement and further identify its influencing factors. DESIGN: A cross-sectional study was performed. METHODS: A total of 323 patients who had undergone bioprosthetic heart valve replacement were recruited from a large-scale tertiary hospital in China between March 2021 and March 2022. The EuroQoL Scale (EQ-5D-5L), Treatment Adherence Scale, and Family Support Scale were used to collect the data. Binary logistic regression was used to analyze the data. RESULTS: The EQ-5D-5L index score was 0.92, and more than half of the patients (53.6%) reported health-related problems. Binary logistic regression analyses revealed that patients with respiratory disease (OR = 2.46, 95% CI [1.23, 4.89]) and heart failure (OR = 3.79, 95% CI [1.12, 12.83]) were risk factors for HRQoL. Treatment adherence (OR = 0.88, 95% CI [0.83, 0.94]) was a protective factor for HRQoL. Family support was not associated with HRQoL (OR = 1.07, 95% CI [0.97, 1.18]). CONCLUSION: Patients undergoing bioprosthetic heart valve replacement reported various health-related problems. Patients who had respiratory disease or heart failure and had lower treatment adherence reported lower HRQoL. IMPACT: Nurses should pay particular attention to HRQoL assessment, treatment adherence, and comorbidity management in routine care and long-term follow-up after bioprosthetic heart valve replacement. REPORTING METHOD: The study followed the STROBE checklist. CONTRIBUTION: No patient or public contribution.

Authors

Institutions

Publication Details

Journal
Nursing Open
Published
2026-06-25
DOI
https://doi.org/10.1002/nop2.70639
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health‐Related Quality of Life and Associated Factors Among Patients With Bioprosthetic Heart Valve Replacement: A Cross‐Sectional Study

Chaoyi Qin, Yunxia Ni, Yanlin Ye, Huang Feng et al.
Nursing Open
Cardiac Valve Diseases and Treatments
article

Health‐Related Quality of Life and Associated Factors Among Patients With Bioprosthetic Heart Valve Replacement: A Cross‐Sectional Study

Chaoyi Qin, Yunxia Ni, Yanlin Ye, Huang Feng, M L Chen, Zhi Li
article en

Abstract

AIM: The use of bioprosthetic heart valves has significantly increased in recent years due to the aging population and advances in technology. Health-related quality of life (HRQoL) is as important as clinical outcomes. However, little is known about the long-term HRQoL of patients after bioprosthetic heart valve replacement and its relationship with comprehensive treatment adherence and family support. The aim of this study was to assess the HRQoL of patients after bioprosthetic heart valve replacement and further identify its influencing factors. DESIGN: A cross-sectional study was performed. METHODS: A total of 323 patients who had undergone bioprosthetic heart valve replacement were recruited from a large-scale tertiary hospital in China between March 2021 and March 2022. The EuroQoL Scale (EQ-5D-5L), Treatment Adherence Scale, and Family Support Scale were used to collect the data. Binary logistic regression was used to analyze the data. RESULTS: The EQ-5D-5L index score was 0.92, and more than half of the patients (53.6%) reported health-related problems. Binary logistic regression analyses revealed that patients with respiratory disease (OR = 2.46, 95% CI [1.23, 4.89]) and heart failure (OR = 3.79, 95% CI [1.12, 12.83]) were risk factors for HRQoL. Treatment adherence (OR = 0.88, 95% CI [0.83, 0.94]) was a protective factor for HRQoL. Family support was not associated with HRQoL (OR = 1.07, 95% CI [0.97, 1.18]). CONCLUSION: Patients undergoing bioprosthetic heart valve replacement reported various health-related problems. Patients who had respiratory disease or heart failure and had lower treatment adherence reported lower HRQoL. IMPACT: Nurses should pay particular attention to HRQoL assessment, treatment adherence, and comorbidity management in routine care and long-term follow-up after bioprosthetic heart valve replacement. REPORTING METHOD: The study followed the STROBE checklist. CONTRIBUTION: No patient or public contribution.

Nursing OpenVol. 13(7)
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Openalex Percentile: Top 7%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.